April 4th 2025
Bispecific antibodies target specific cells, offering effective treatment for relapsed/refractory multiple myeloma, with varying side effect profiles.
April 2nd 2025
March 10th 2025
March 7th 2025
March 6th 2025
March 5th 2025
March 31st 2025
March 3rd 2025
February 23rd 2025
February 22nd 2025